The Resource Cancer : principles & practice of oncology, editors, Vincent T. DeVita Jr., Theodore S. Lawrence, Steven A. Rosenberg

Cancer : principles & practice of oncology, editors, Vincent T. DeVita Jr., Theodore S. Lawrence, Steven A. Rosenberg

Label
Cancer : principles & practice of oncology
Title
Cancer
Title remainder
principles & practice of oncology
Statement of responsibility
editors, Vincent T. DeVita Jr., Theodore S. Lawrence, Steven A. Rosenberg
Title variation
Cancer
Title variation remainder
principles and practice of oncology
Contributor
Subject
Language
eng
Member of
Action
committed to retain for EAST
Cataloging source
DNLM/DLC
Illustrations
illustrations
Index
index present
Literary form
non fiction
Nature of contents
bibliography
NLM call number
QZ 200
NLM item number
C21537 2010
http://library.link/vocab/relatedWorkOrContributorDate
1935-
http://library.link/vocab/relatedWorkOrContributorName
  • DeVita, Vincent T.
  • Lawrence, Theodore S
  • Rosenberg, Steven A
Series statement
Annual advances in oncology
Series volume
v. 1
http://library.link/vocab/subjectName
  • Cancer
  • Neoplasms
Label
Cancer : principles & practice of oncology, editors, Vincent T. DeVita Jr., Theodore S. Lawrence, Steven A. Rosenberg
Instantiates
Publication
Bibliography note
Includes bibliographical references and index
Contents
  • Christine Duffy and Susan Allen
  • Sexual rehabilitation after localized prostate cancer: current interventions and future directions
  • David M. Latini ... [et al.]
  • Sexual side effects and prostate cancer treatment decisions: patient information needs and preferences
  • Sara J. Knight and David M. Latini
  • Interventions for sexuality after pelvic radiation therapy and gynecological cancer
  • Anne Katz
  • A review of couple-based interventions for enhancing women's sexual adjustment and body image after cancer
  • Jennifer L. Scott and Karen Kayser
  • Sexuality after hematopoietic stem cell transplantation
  • Part I: Sexuality after cancer
  • Jean C. Yi and Karen L. Syrjala
  • Sexual functioning after cancer in sexual minority women
  • Ulrike Boehmer, Jennifer Potter, and Deborah J. Bowen
  • In sickness and in health: maintaining intimacy after breast cancer recurrence
  • Barbara L. Andersen
  • Sexual health comunication during cancer care: barriers and recommendations
  • Elyse R. Park, Rebecca L. Norris, and Sharon L. Bober --
  • Out in the open: addressing sexual health after cancer
  • Sharon L. Bober
  • Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers
  • Ellen T. Matloff, Rachel E. Barnett, and Sharon L. Bober
  • Concerns about sexuality after breast cancer
  • Patricia Fobair and David Spiegel
  • Medical and psychosocial aspects of fertility after cancer
  • Franziska C. Eberle, Haresh Mani, and Elaine S. Jaffe
  • Hodgkin's lymphoma--patients assessment and staging
  • Mary K. Gospodarowicz
  • Combined modality treatment of Hodgkin's lymphoma
  • Beate Klimm and Andreas Engert
  • Role of chemotherapy in Hodgkin's lymphoma
  • Pamela Seam ... [et al.]
  • Role of radiation therapy in Hodgkin's lymphoma
  • Joachim Yahalom
  • Salvage therapy for Hodgkin's lymphoma
  • Part II: Hodgkin's lymphoma
  • Fahd Quddus and James O. Armitage
  • Late effects of Hodgkin's disease and its treatment
  • Andrea K. Ng and Peter M. Mauch --
  • Hodgkin's lymphoma: an overview
  • Dan L. Longo
  • Current insight on trends, causes, and mechanisms of Hodgkin's lymphoma
  • Neil E. Caporaso ... [et al.]
  • Clinical manifestations and natural history of Hodgkin's lymphoma
  • Joseph M. Connors
  • Histopathology of Hodgkin's lymphoma
  • Alfredo Garofalo and Mario Valle
  • Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve
  • Faheez Mohamed and Brendan J. Moran
  • Cytoreductive surgery plus intraperitoneal chemohyperthermia in patients with colorectal cancer at high risk for local-regional recurrence
  • Jeremie H. Lefevre and Dominique M. Elias
  • Surgical techniques in visceral resection and peritonectomy procedures
  • Philip Bao and David Bartlett
  • Long-term results of cytoreduction and HIPEC followed by systemic chemotherapy
  • Vic J. Verwaal
  • Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancy
  • Part III: Management of peritoneal carcinomatosis from colorectal and appendiceal malignancy
  • Kurt Van Der Speeten, Oswald A. Stuart, and Paul H. Sugarbaker
  • Epithelial appendiceal neoplasms
  • Paul H. Sugarbaker
  • Patient selection for a curative approach to carcinomatosis
  • Pompiliu Piso ... [et al.]
  • Management of peritoneal carcinomatosis from colorectal cancer: current state of practice
  • Eddy Cotte ... [et al.]
  • Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan, and Korea
  • Jesus Esquivel --
  • Peritoneal surface malignancies: a real challenge for surgeons
  • Franc̦ois Noël Gilly
  • Progress in the management of carcinomatosis
  • Paul H. Sugarbaker
  • Imaging of peritoneal carcinomatosis
  • Santiago González-Moreno ... [et al.]
  • Laparoscopy in the management of peritoneal carcinomatosis
  • Jacob Flanz and Alfred Smith
  • Proton beam therapy in pediatric oncology
  • Thomas E. Merchant
  • The clinical experience with particle therapy in adults
  • Daniela Schulz-Ertner
  • Life, liberty, and the pursuit of protons: an evidence-based review of the role of particle therapy in the treatment of prostate cancer
  • Jason A. Efstathiou, Alexei V. Trofimov, and Anthony L. Zietman
  • Current clinical evidence for proton therapy
  • Michael Brada, Madelon Pijls-Johannesma, and Dirk de Ruysscher
  • Comparison of carbon ions versus protons
  • Part IV: Charged particle therapy
  • Uli Weber and Gerhard Kraft
  • Proton beam therapy and the convoluted pathway to incorporating emerging technology into routine medical care in the United States
  • Michael L. Steinberg and Andre Konski --
  • Particle therapy in all its parts
  • Benjamin Movsas and Theodore S. Lawrence
  • Biology of charged particles
  • Eleanor A. Blakely and Polly Y. Chang
  • Charged particle therapy: the physics of interaction
  • Antony J. Lomax
  • Technology for proton therapy
  • Tatiana Vidaurre ... [et al.]
  • Stable disease is a valid end point in clinical trials /
  • r Anthony W. Tolcher
  • Progression-free survival is simply a measure of a drug's effect while administered and is not a surrogate for overall survival
  • Julia Wilkerson and Tito Fojo
  • Progression-free survival: gaining on overall survival as a gold standard and accelerating drug development
  • David Lebwohl ... [et al.]
  • Overall survival: a gold standard in search of a surrogate: the value of progression-free survival and time to progression as end points of drug efficacy
  • Sen H. Zhuang, Liang Xiu, and Yusri A. Elsayed
  • Overall survival: still the gold standard: why overall survival remains the definitive end point in cancer clinical trials
  • Part V: Monitoring of therapeutic responses to cancer treatment
  • James J. Driscoll and Oliver Rixe
  • Biomarker-driven early clinical trials in oncology: a paradigm shift in drug development
  • Daniel S. W. Tan ... [et al.]
  • Use of meta-analysis for the validation of surrogate endpoints and biomarkers in cancer trials
  • Marc Buyse
  • Other paradigms: better treatments are identified by better trials: the value of randomized phase II studies
  • Manish R. Sharma, Michael L. Maitland, and Mark J. Ratain
  • Other paradigms: randomized discontinuation trial design
  • Walter Stadler
  • Other paradigms: health-related quality of life as a measure in cancer treatment: its importance and relevance
  • Monitoring of therapeutic response to cancer treatment
  • Peter C. Trask, Ming-Ann Hsu, and Richard McQuellon
  • Other paradigms: growth rate constants and tumor burden determined using computed tomography data correlate strongly with the overall survival of patients with renal cell carcinoma
  • Wilfred D. Stein ... [et al.] --
  • Tito Fojo
  • Tumor shrinkage and objective response rates: gold standard for oncology efficacy screening trials, or an outdated end point?
  • Penelope Bradbury and Lesley Seymour
  • Response rates: a valuable signal of promising activity?
  • Xavier Pivot ... [et al.]
  • Stable disease is not preferentially observed with targeted therapies and as currently defined has limited value in drug development
  • Sigurdur Yngvi Kristinsson, Ola Landgren, and Vincent S. Rajkumar
  • Integrating novel therapies in the transplant paradigm
  • Jean-Luc Harousseau
  • Novel agents for relapsed and/or refractory multiple myeloma
  • Sheeba K. Thomas, Tiffany A. Richards, and Donna M. Weber
  • Evolving role of novel agents for maintenance therapy in myeloma
  • Valeria Magarotto and Antonio Palumbo
  • Novel immunotherapies
  • Qing Yi
  • Future novel single agent and combination therapies
  • Part VI: New therapies for myeloma: impact on survival
  • Diana Cirstea, Sonia Vallet, and Noopur Raje
  • The evolving treatment paradigm in multiple myeloma
  • Kenneth C. Anderson
  • Risk stratification in the era of novel therapies
  • Jesus San-Miguel, M. Victoria Mateos, and Norma C. Gutierrez
  • The importance of complete response in outcomes in myeloma
  • Ajay Nooka, Jonathan Kaufman, and Sagar Lonial
  • Novel therapies in multiple myeloma for newly diagnosed nontransplant candidates
Dimensions
26 cm.
Extent
xx, 427 p.
Isbn
9781451103144
Isbn Type
(alk. paper)
Lccn
20100171 59
Other physical details
ill. (chiefly col.)
System control number
  • (OCoLC)610144573
  • (OCoLC)610144573
Label
Cancer : principles & practice of oncology, editors, Vincent T. DeVita Jr., Theodore S. Lawrence, Steven A. Rosenberg
Publication
Bibliography note
Includes bibliographical references and index
Contents
  • Christine Duffy and Susan Allen
  • Sexual rehabilitation after localized prostate cancer: current interventions and future directions
  • David M. Latini ... [et al.]
  • Sexual side effects and prostate cancer treatment decisions: patient information needs and preferences
  • Sara J. Knight and David M. Latini
  • Interventions for sexuality after pelvic radiation therapy and gynecological cancer
  • Anne Katz
  • A review of couple-based interventions for enhancing women's sexual adjustment and body image after cancer
  • Jennifer L. Scott and Karen Kayser
  • Sexuality after hematopoietic stem cell transplantation
  • Part I: Sexuality after cancer
  • Jean C. Yi and Karen L. Syrjala
  • Sexual functioning after cancer in sexual minority women
  • Ulrike Boehmer, Jennifer Potter, and Deborah J. Bowen
  • In sickness and in health: maintaining intimacy after breast cancer recurrence
  • Barbara L. Andersen
  • Sexual health comunication during cancer care: barriers and recommendations
  • Elyse R. Park, Rebecca L. Norris, and Sharon L. Bober --
  • Out in the open: addressing sexual health after cancer
  • Sharon L. Bober
  • Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers
  • Ellen T. Matloff, Rachel E. Barnett, and Sharon L. Bober
  • Concerns about sexuality after breast cancer
  • Patricia Fobair and David Spiegel
  • Medical and psychosocial aspects of fertility after cancer
  • Franziska C. Eberle, Haresh Mani, and Elaine S. Jaffe
  • Hodgkin's lymphoma--patients assessment and staging
  • Mary K. Gospodarowicz
  • Combined modality treatment of Hodgkin's lymphoma
  • Beate Klimm and Andreas Engert
  • Role of chemotherapy in Hodgkin's lymphoma
  • Pamela Seam ... [et al.]
  • Role of radiation therapy in Hodgkin's lymphoma
  • Joachim Yahalom
  • Salvage therapy for Hodgkin's lymphoma
  • Part II: Hodgkin's lymphoma
  • Fahd Quddus and James O. Armitage
  • Late effects of Hodgkin's disease and its treatment
  • Andrea K. Ng and Peter M. Mauch --
  • Hodgkin's lymphoma: an overview
  • Dan L. Longo
  • Current insight on trends, causes, and mechanisms of Hodgkin's lymphoma
  • Neil E. Caporaso ... [et al.]
  • Clinical manifestations and natural history of Hodgkin's lymphoma
  • Joseph M. Connors
  • Histopathology of Hodgkin's lymphoma
  • Alfredo Garofalo and Mario Valle
  • Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve
  • Faheez Mohamed and Brendan J. Moran
  • Cytoreductive surgery plus intraperitoneal chemohyperthermia in patients with colorectal cancer at high risk for local-regional recurrence
  • Jeremie H. Lefevre and Dominique M. Elias
  • Surgical techniques in visceral resection and peritonectomy procedures
  • Philip Bao and David Bartlett
  • Long-term results of cytoreduction and HIPEC followed by systemic chemotherapy
  • Vic J. Verwaal
  • Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancy
  • Part III: Management of peritoneal carcinomatosis from colorectal and appendiceal malignancy
  • Kurt Van Der Speeten, Oswald A. Stuart, and Paul H. Sugarbaker
  • Epithelial appendiceal neoplasms
  • Paul H. Sugarbaker
  • Patient selection for a curative approach to carcinomatosis
  • Pompiliu Piso ... [et al.]
  • Management of peritoneal carcinomatosis from colorectal cancer: current state of practice
  • Eddy Cotte ... [et al.]
  • Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan, and Korea
  • Jesus Esquivel --
  • Peritoneal surface malignancies: a real challenge for surgeons
  • Franc̦ois Noël Gilly
  • Progress in the management of carcinomatosis
  • Paul H. Sugarbaker
  • Imaging of peritoneal carcinomatosis
  • Santiago González-Moreno ... [et al.]
  • Laparoscopy in the management of peritoneal carcinomatosis
  • Jacob Flanz and Alfred Smith
  • Proton beam therapy in pediatric oncology
  • Thomas E. Merchant
  • The clinical experience with particle therapy in adults
  • Daniela Schulz-Ertner
  • Life, liberty, and the pursuit of protons: an evidence-based review of the role of particle therapy in the treatment of prostate cancer
  • Jason A. Efstathiou, Alexei V. Trofimov, and Anthony L. Zietman
  • Current clinical evidence for proton therapy
  • Michael Brada, Madelon Pijls-Johannesma, and Dirk de Ruysscher
  • Comparison of carbon ions versus protons
  • Part IV: Charged particle therapy
  • Uli Weber and Gerhard Kraft
  • Proton beam therapy and the convoluted pathway to incorporating emerging technology into routine medical care in the United States
  • Michael L. Steinberg and Andre Konski --
  • Particle therapy in all its parts
  • Benjamin Movsas and Theodore S. Lawrence
  • Biology of charged particles
  • Eleanor A. Blakely and Polly Y. Chang
  • Charged particle therapy: the physics of interaction
  • Antony J. Lomax
  • Technology for proton therapy
  • Tatiana Vidaurre ... [et al.]
  • Stable disease is a valid end point in clinical trials /
  • r Anthony W. Tolcher
  • Progression-free survival is simply a measure of a drug's effect while administered and is not a surrogate for overall survival
  • Julia Wilkerson and Tito Fojo
  • Progression-free survival: gaining on overall survival as a gold standard and accelerating drug development
  • David Lebwohl ... [et al.]
  • Overall survival: a gold standard in search of a surrogate: the value of progression-free survival and time to progression as end points of drug efficacy
  • Sen H. Zhuang, Liang Xiu, and Yusri A. Elsayed
  • Overall survival: still the gold standard: why overall survival remains the definitive end point in cancer clinical trials
  • Part V: Monitoring of therapeutic responses to cancer treatment
  • James J. Driscoll and Oliver Rixe
  • Biomarker-driven early clinical trials in oncology: a paradigm shift in drug development
  • Daniel S. W. Tan ... [et al.]
  • Use of meta-analysis for the validation of surrogate endpoints and biomarkers in cancer trials
  • Marc Buyse
  • Other paradigms: better treatments are identified by better trials: the value of randomized phase II studies
  • Manish R. Sharma, Michael L. Maitland, and Mark J. Ratain
  • Other paradigms: randomized discontinuation trial design
  • Walter Stadler
  • Other paradigms: health-related quality of life as a measure in cancer treatment: its importance and relevance
  • Monitoring of therapeutic response to cancer treatment
  • Peter C. Trask, Ming-Ann Hsu, and Richard McQuellon
  • Other paradigms: growth rate constants and tumor burden determined using computed tomography data correlate strongly with the overall survival of patients with renal cell carcinoma
  • Wilfred D. Stein ... [et al.] --
  • Tito Fojo
  • Tumor shrinkage and objective response rates: gold standard for oncology efficacy screening trials, or an outdated end point?
  • Penelope Bradbury and Lesley Seymour
  • Response rates: a valuable signal of promising activity?
  • Xavier Pivot ... [et al.]
  • Stable disease is not preferentially observed with targeted therapies and as currently defined has limited value in drug development
  • Sigurdur Yngvi Kristinsson, Ola Landgren, and Vincent S. Rajkumar
  • Integrating novel therapies in the transplant paradigm
  • Jean-Luc Harousseau
  • Novel agents for relapsed and/or refractory multiple myeloma
  • Sheeba K. Thomas, Tiffany A. Richards, and Donna M. Weber
  • Evolving role of novel agents for maintenance therapy in myeloma
  • Valeria Magarotto and Antonio Palumbo
  • Novel immunotherapies
  • Qing Yi
  • Future novel single agent and combination therapies
  • Part VI: New therapies for myeloma: impact on survival
  • Diana Cirstea, Sonia Vallet, and Noopur Raje
  • The evolving treatment paradigm in multiple myeloma
  • Kenneth C. Anderson
  • Risk stratification in the era of novel therapies
  • Jesus San-Miguel, M. Victoria Mateos, and Norma C. Gutierrez
  • The importance of complete response in outcomes in myeloma
  • Ajay Nooka, Jonathan Kaufman, and Sagar Lonial
  • Novel therapies in multiple myeloma for newly diagnosed nontransplant candidates
Dimensions
26 cm.
Extent
xx, 427 p.
Isbn
9781451103144
Isbn Type
(alk. paper)
Lccn
20100171 59
Other physical details
ill. (chiefly col.)
System control number
  • (OCoLC)610144573
  • (OCoLC)610144573

Library Locations

  • African Studies LibraryBorrow it
    771 Commonwealth Avenue, 6th Floor, Boston, MA, 02215, US
    42.350723 -71.108227
  • Alumni Medical LibraryBorrow it
    72 East Concord Street, Boston, MA, 02118, US
    42.336388 -71.072393
  • Astronomy LibraryBorrow it
    725 Commonwealth Avenue, 6th Floor, Boston, MA, 02445, US
    42.350259 -71.105717
  • Fineman and Pappas Law LibrariesBorrow it
    765 Commonwealth Avenue, Boston, MA, 02215, US
    42.350979 -71.107023
  • Frederick S. Pardee Management LibraryBorrow it
    595 Commonwealth Avenue, Boston, MA, 02215, US
    42.349626 -71.099547
  • Howard Gotlieb Archival Research CenterBorrow it
    771 Commonwealth Avenue, 5th Floor, Boston, MA, 02215, US
    42.350723 -71.108227
  • Mugar Memorial LibraryBorrow it
    771 Commonwealth Avenue, Boston, MA, 02215, US
    42.350723 -71.108227
  • Music LibraryBorrow it
    771 Commonwealth Avenue, 2nd Floor, Boston, MA, 02215, US
    42.350723 -71.108227
  • Pikering Educational Resources LibraryBorrow it
    2 Silber Way, Boston, MA, 02215, US
    42.349804 -71.101425
  • School of Theology LibraryBorrow it
    745 Commonwealth Avenue, 2nd Floor, Boston, MA, 02215, US
    42.350494 -71.107235
  • Science & Engineering LibraryBorrow it
    38 Cummington Mall, Boston, MA, 02215, US
    42.348472 -71.102257
  • Stone Science LibraryBorrow it
    675 Commonwealth Avenue, Boston, MA, 02445, US
    42.350103 -71.103784
Processing Feedback ...